BMC Infectious Diseases
(Accessed 2 Nov 2019)
Mass campaigns combining antimalarial drugs and anti-infective vaccines as seasonal interventions for malaria control, elimination and prevention of resurgence: a modelling study
The only licensed malaria vaccine, RTS,S/AS01, has been developed for morbidity-control in young children. The potential impact on transmission of deploying such anti-infective vaccines to wider age ranges, possibly with co-administration of antimalarial treatment, is unknown. Combinations of existing malaria interventions is becoming increasingly important as evidence mounts that progress on reducing malaria incidence is stalling and threatened by resistance.
Authors: Flavia Camponovo, Chris F. Ockenhouse, Cynthia Lee and Melissa A. Penny
Citation: BMC Infectious Diseases 2019 19:920
Published on: 29 October 2019